HOME
SEARCH
RSS FEED
SUBSCRIBE
Development of Reagents to Examine the Expression and Function of CYP2J Subfamily P450s
Case ID:
TAB-572
Web Published:
12/6/2022
Description:
Cytochrome P450s catalyze the metabolism of a wide range of exogenous compounds, including drugs, industrial chemicals, environmental pollutants, and carcinogens. The 2C family of cytochrome P450 metabolizes an extensive number of drugs which include tolbutamide, S-Warfarin, mephenytoin, diazepam and taxol. The inventors cloned the cDNAs for several different CYP2J subfamily members including human CYP2J2, rat CYP2J3, mouse CYP2J5, mouse CYP2J6, and mouse CYP2J9. The recombinant proteins were expressed in insect cells. Additionally, the inventors also developed specific peptide-based antibodies to these P450 proteins and characterized their specificity and cross-reactivity by immunoblotting.
The following materials are available for licensing for commercial use:
human CYP2J2 cDNA
rat CYP2J3 cDNA
mouse CYP2J5 cDNA
mouse CYP2J9 cDNA
anti-CYP2J2rec (cross-reacts with all CYP2Js)
anti-CYPeJ2pep2 (human CYP2J2 specific)
anti-CYP2J9pep2 (cross-reacts with rat CYP2J3 and mouse CYp2J9)
anti-CYP2J5pep (mouse CYP2J5 specific)
anti-CYP2J6pep (cross reacts with rat CYP2J4 and mouse CYP2J6)
CYP2J2-CRPOR microsomes (baculovirus expressed)
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Direct Link:
https://nih.technologypublisher.com/tech/Development_of_Reagents_to_Examine_t he_Expression_and_Function_of_CYP2J_Subfamily_P450s
Category(s):
Collaboration
Research Materials
Bookmark this page
Download as PDF
For Information, Contact:
Vidita Choudhry
Technology Development Specialist
NIH Technology Transfer
301-594-4095
vidita.choudhry@nih.gov
Inventors:
Darryl Zeldin
Jennifer Bradbury
Keywords:
CYP2J
Development
Examine
Expression
FUNCTION
Listed LPM Contreras as of 4/15/2015
P450s
Post LPM Assignment Set 20150420
Pre LPM working set 20150418
R1XXXX
REAGENTS
RXXXXX
SUBFAMILY
Home
|
Search
|
RSS
|
Subscribe
© 2024. All Rights Reserved. Powered by
Inteum